美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

INVESCO BIOTECHNOLOGY & GENOME ETF

95.14

+1.771.89%

成交量：8,380

成交額：79.70萬

市值：4.13億

市盈率：53.05

高：95.42

開：94.85

低：94.77

收：93.37

52周最高：98.82

52周最低：67.69

股本：434.00萬

流通股本：434.00萬

量比：1.03

換手率：0.19%

股息：1.55

股息率：1.63%

每股收益(TTM):1.79

每股收益(LYR):18.65

淨資產收益率：24.76%

總資產收益率：0.08%

市淨率：1.67

市盈率(LYR):5.10

資料載入中...

總覽公司新聞資訊公告

安進（AMGN）降脂藥Repatha新臨床數據：可降低未發生心梗或中風高危患者20%死亡風險

藥聞 | 英硅智能上市後首份半年報扭虧創新藥研發加速擁抱AI

樂意保®（侖卡奈單抗）皮下自動注射劑型LEQEMBI IQLIK®在美上市，適用於早期阿爾茨海默病的初始治療

聯環藥業上半年扭虧為盈集採續採與創新藥研發協同推進

Alnylam和Ionis股價下跌，因心臟病藥物數據引發對聯合治療的質疑

博濟醫藥2026年半年報：創新藥研發需求復甦，在手訂單充足，經營現金流明顯下滑

英國股市——8月27日需關注的因素

阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標

Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果，共同主要終點及所有關鍵次要終點全面達標

衞材公司：Leqembi Iqlik（Lecanemab-Irmb）自動注射器現已在美國上市，用於早期阿爾茨海默病治療啓動

美國聯邦貿易委員會（FTC）：安進專利申請收購交易受到反壟斷審查。

Piper Sandler上調安進目標價至457美元

美國研究綜述-安進、Analog Devices、莫德納

福泰製藥(VRTX)股票8月19日收盤上漲4.48%：釋放什麼信號？

TradingKey中文

安進(AMGN)股票8月19日盤中上漲3.19%：背後推手曝光

TradingKey中文

瑞穗上調安進目標價至352美元

駿利亨德森投資：專利到期倒逼藥企擴張生物科技併購、IPO市場同步復甦

智通财经网

藥代違規進入診療區域！湘雅二醫院發藥品「停用函」，艾力斯、賽諾菲、安進、康蒂尼四藥企上「黑榜」

TScan Therapeutics披露：安進將終止與其研究合作及許可協議

巴克萊上調安進目標價至380美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/PBE/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PBE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":95.135,"timestamp":1789668346538,"preClose":93.3693,"halted":0,"volume":8380,"delay":0,"changeRate":0.018910926824984332,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"交易中","change":1.7657,"latestTime":"09-17 14:08:29 EDT","open":94.85,"high":95.42,"low":94.765,"amount":797042.8338,"amplitude":0.007015,"askPrice":95.41,"askSize":400,"bidPrice":95.22,"bidSize":500,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":93.3693,"sharesOutstanding":3180000,"nav":93.02867,"aum":405605001.2,"dividendRate":0.016292,"bidAskSpread":0.001979,"preHourTrading":{"tag":"盘前","latestPrice":93.3693,"preClose":93.3693,"latestTime":"07:00 EDT","volume":1,"amount":93.3693,"timestamp":1789642840517,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":92.89213,"preClose":93.3693,"latestTime":"19:30 EDT","volume":12,"amount":1120.613,"timestamp":1789601405975,"change":-0.47717,"changeRate":-0.005111,"amplitude":0},"volumeRatio":1.032633,"impliedVol":0.1149,"impliedVolPercentile":0.0359},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBE\",,,,,undefined,":{"symbol":"PBE","floatShares":4340000,"roa":"0.08%","roe":"24.76%","lyrEps":18.654418,"volumeRatio":1.032633,"shares":4340000,"dividePrice":1.5499,"high":95.42,"amplitude":0.007015,"preClose":93.3693,"low":94.765,"week52Low":67.69,"pbRate":"1.67","psRate":"240.52","week52High":98.82,"institutionHeld":0.2552,"latestPrice":95.135,"committee":0.111111,"eps":1.793292,"divideRate":0.016292,"volume":8380,"delay":0,"ttmEps":1.793292,"open":94.85,"prevYearClose":82.15,"prevWeekClose":92.91,"prevMonthClose":96.68,"prevQuarterClose":89.6486,"fiveDayClose":93.03,"twentyDayClose":98.2643,"sixtyDayClose":85.4379},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBE\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"PBE","amount":0.81061,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PBE","amount":0.08244,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PBE","amount":0.41972,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PBE","amount":0.23409,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PBE","amount":0.13047,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"INVESCO BIOTECHNOLOGY & GENOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.02834,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.1208,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.05552,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.21532,"currency":"USD"},{"executeDate":"2018-09-24","recordDate":"2018-09-25","paymentDate":"2018-09-28","value":0.00207,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBE\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663778550","title":"安進（AMGN）降脂藥Repatha新臨床數據：可降低未發生心梗或中風高危患者20%死亡風險","url":"https://stock-news.laohu8.com/highlight/detail?id=2663778550","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663778550?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:48","pubTimestamp":1788173287,"startTime":"0","endTime":"0","summary":"研究结果显示，对于既往未发生过心肌梗死或中风的高危成年患者，在接受他汀类或其他降脂疗法的基础上加用Repatha，可显著降低20%的全因死亡风险，同时有效降低心血管死亡率。数据显示，Repatha能在治疗开启最早6个月内降低心梗风险，且将患者低密度脂蛋白胆固醇中位数降低至45mg/dL，远优于安慰剂组的109mg/dL。此外，欧盟委员会已于2026年8月批准扩大Repatha在欧洲的适应症，用于确诊或高危确诊的动脉粥样硬化性心血管疾病成年患者降低心血管风险。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/Mjk1NzA2YjQxMDg1MTQ0MjI1MzE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Mjk1NzA2YjQxMDg1MTQ0MjI1MzE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305491","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","IE0002141913.USD","LU0289739699.SGD","LU1061106388.HKD","LU2242652126.USD","BBH","LU0122379950.USD","BK4566","LU0889565916.HKD","IBBQ","TBXU","LU1057294990.SGD","AMGN","IE00BFTCPJ56.SGD","PBE","LU2242646821.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4585","BK4534","BK4533","IE00BJT1NW94.SGD","SG9999001440.SGD","BK4581","LU0868494617.USD","LU0109394709.USD","LU1571399168.USD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU1023059063.AUD","LU2112291526.USD","BK4599","LU2089984988.USD","IE0009355771.USD","BIB","BK4139","LU0058720904.USD","PJP","BK4588","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663282078","title":"藥聞 | 英硅智能上市後首份半年報扭虧 創新藥研發加速擁抱AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2663282078","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663282078?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 15:35","pubTimestamp":1788161758,"startTime":"0","endTime":"0","summary":"新华财经上海8月31日电（记者杜康）作为AI制药领域代表性企业之一，英硅智能（03696.HK）日前发布2026年度中期业绩报告。上半年，公司实现总营收1.063亿美元，同比增长287.2%；净利润3554万美元，经调整净利润5123万美元，经营活动现金流转正。这是英硅智能上市后发布的首份半年报，公司也由此前的亏损转为盈利。从收入结构看，药物研发与管线开发仍是主要来源。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860072952.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860072952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["AGIX","GSKH","IPOS","APXH","BIOY","XLVI","AIPO","LFSC","CHAT","BBP","BK4585","VTHR","BK4588","SBIO","IBB","WRND","ARTY","QTOC","GDOC","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663734390","title":"樂意保®（侖卡奈單抗）皮下自動注射劑型LEQEMBI IQLIK®在美上市，適用於早期阿爾茨海默病的初始治療","url":"https://stock-news.laohu8.com/highlight/detail?id=2663734390","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663734390?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 14:47","pubTimestamp":1788158820,"startTime":"0","endTime":"0","summary":"乐意保皮下自动注射剂型已获美国FDA批准，是全球首个可为初始治疗和维持治疗提供居家给药选择的抗淀粉样蛋白疗法。贯穿阿尔茨海默病治疗全程，提升治疗便利性与灵活性 在美国，乐意保皮下自动注射剂型已可用于初始治疗及维持治疗。该剂型有望进一步提升治疗的便利性和灵活性，使早期阿尔茨海默病患者及其照护伙伴在疾病管理中获得更大的自主权，同时可能降低患者启动和持续使用乐意保治疗的阻碍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5036748_ZH36748_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5036748_ZH36748_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["IE00B894F039.SGD","PBE","LU0234570918.USD","BK4533","BMED","IE00B19Z9Z06.USD","LU0320765992.SGD","BK4139","LU0889565916.HKD","BK4588","LU0109394709.USD","BK4585","BK4532","IE00B19Z9P08.USD","BIIB","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663044177","title":"聯環藥業上半年扭虧為盈 集採續採與創新藥研發協同推進","url":"https://stock-news.laohu8.com/highlight/detail?id=2663044177","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663044177?lang=zh_tw&edition=fundamental","pubTime":"2026-08-30 21:12","pubTimestamp":1788095520,"startTime":"0","endTime":"0","summary":"业绩实现扭亏为盈经营基本面持续改善今年上半年，联环药业经营业绩实现明显改善。对此，联环药业正持续推进相关工作。值得注意的是，联环药业已经开始围绕创新药商业化进行营销体系布局。除LH-1801外，联环药业产品注册申报也取得阶段性进展。从核心产品稳定销售，到集采品种持续放量，再到创新药研发向上市申报环节推进，联环药业正在逐步形成多层次的业务增长支撑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-30/doc-iniqcfmp8061523.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-30/doc-iniqcfmp8061523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBB","600513","LFSC","BBP","BK0239","GSKH","BIOY","GDOC","WRND","XLVI","PBE","BK4588","BK4585","SBIO","APXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662709336","title":"Alnylam和Ionis股價下跌，因心臟病藥物數據引發對聯合治療的質疑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662709336","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662709336?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 20:43","pubTimestamp":1787921029,"startTime":"0","endTime":"0","summary":"BUZZ-Alnylam和Ionis股价下跌，因心脏病药物数据引发对联合治疗的质疑8月28日-** 盘前交易中，Alnylam Pharmaceuticals（ALNY.O）股价下跌5.3%，报224美元；Ionis Pharmaceuticals（IONS.O）股价下跌1.3%，报61.62美元** 在欧洲心脏病学会（ESC）年会上公布的详细数据显示，阿斯利康（AZN.L）与Ionis的实验性药","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4S44P0Z8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALNY","LU0320765992.SGD","LU0889565916.HKD","BK4585","LU0109394709.USD","LU0114720955.EUR","GNMX","BK4548","LU0882574055.USD","PBE","BK4588","BK4139","IONS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752987","title":"博濟醫藥2026年半年報：創新藥研發需求復甦，在手訂單充足，經營現金流明顯下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752987","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752987?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:57","pubTimestamp":1787813849,"startTime":"0","endTime":"0","summary":"然而，需警惕新药研发政策变化、项目执行延期及市场竞争加剧带来的风险，同时关注经营现金流与净利润背离的情况。后续需重点关注公司在手订单转化进度、临床前及临床研究服务的毛利率变化趋势，以及经营现金流的改善情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787797151251328663","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4585","LFSC","GSKH","BBP","XLVI","300404","BK4588","SPHQ","BK0216","IBB","GDOC","PBE","SBIO","WRND","APXH","BIOY","159399"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775484","title":"英國股市——8月27日需關注的因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775484","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775484?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:53","pubTimestamp":1787813617,"startTime":"0","endTime":"0","summary":"更新 1-英国股市——8月27日需关注的因素新增新闻报导，更新期货行情路透8月27日-预计周四英国富时100指数.FTSE将低开，期货FFIc1下跌0.4%。*7月汽车产量：行业数据显示，受出口疲软及部分工厂提前进行夏季检修停产影响，英国7月汽车产量  同比下降11.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GAW.UK","LU1119994496.HKD","LU1267930227.SGD","BBH","LU0963555726.SGD","PJP","LU0949170426.SGD","LU0310800379.SGD","LU0868494617.USD","LU0171276677.USD","LU2089984988.USD","GLEN.UK","PRU.UK","LU0075056555.USD","LU0345777147.USD","LU1057294990.SGD","SG9999001176.SGD","LU1880407132.USD","LU1355424745.HKD","IBB","LU0345780950.USD","CRDA.UK","SGXZ57979304.SGD","LU1989771016.USD","TBXU","BK5105","IBBQ","LU0553294199.USD","LU0047713382.USD","LU0792757196.USD","LU0171293334.USD","LU0969580561.USD","03165","LU2293690082.USD","BK4139","HFD.UK","BIB","PPH.UK","IE0034235188.USD","LU0211326755.USD","LU0889565916.HKD","LU1267930573.SGD","AMGN","AZN.UK","LU1989772923.USD","PBE","BK4585","LU1104425308.USD","LU0122379950.USD","LU0857590862.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662639773","title":"阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2662639773","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662639773?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:08","pubTimestamp":1787810905,"startTime":"0","endTime":"0","summary":"阿斯利康的哮喘药物Tezspire在食管炎晚期临床试验中达到了所有目标路透8月27日-阿斯利康（AstraZeneca）AZN.L周四表示，其与安进（Amgen）AMGN.O联合开发的哮喘药物Tezspire，在治疗嗜酸性粒细胞性食管炎（一种食管的慢性炎症性疾病）的晚期临床试验中达到了主要和次要研究目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203345920.USD","LU2237443549.SGD","BIB","PBE","LU0211328371.USD","LU1119994496.HKD","LU0171276677.USD","LU1273509221.SGD","LU0882574055.USD","BK4599","LU0390134368.USD","TBXU","LU1015430645.USD","LU0211327993.USD","LU0496365809.HKD","LU1261432733.SGD","LU1267930813.SGD","LU1923622614.USD","IE00B2B36J28.USD","BBH","LU2125909247.SGD","BK5011","AZN.UK","LU1989772840.SGD","LU0640478417.SGD","LU2089284900.SGD","LU0557290698.USD","PJP","LU0011850046.USD","BK4588","LU0889565916.HKD","LU1061106388.HKD","LU0757432116.USD","LU1196032939.SGD","IBBQ","AMGN","LU0158827948.USD","LU1481599808.USD","LU0960981461.USD","LU0823416689.USD","LU0949170426.SGD","LU1323610961.USD","LU1064927863.SGD","03165","IE00BFTCPJ56.SGD","LU0432979614.USD","IBB","BK4139","LU0526926950.USD","LU2357627491.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146489142","title":"Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果，共同主要終點及所有關鍵次要終點全面達標","url":"https://stock-news.laohu8.com/highlight/detail?id=1146489142","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146489142?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810443,"startTime":"0","endTime":"0","summary":"Tezspire在针对嗜酸性食管炎的III期临床试验中取得了令人瞩目的积极结果。该试验不仅成功达到了共同主要终点，而且所有关键次要终点也悉数告捷。Tezspire的优异表现，标志着该领域治疗可能迎来重大变革。共同主要终点的同时达成，以及关键次要终点的全面覆盖，充分验证了Tezspire的疗效一致性和临床获益的广泛性。业内专家指出，Tezspire的这项研究成果，不仅巩固了其在炎症性疾病治疗领域的地位，更可能为后续的监管审批和市场推广奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0002141913.USD","LU1571399168.USD","LU2242652126.USD","AMGN","LU0320765992.SGD","LU1061106388.HKD","BK4581","LU2089984988.USD","LU1023059063.AUD","LU0122379950.USD","LU0109394709.USD","PJP","BK4534","IBB","PBE","LU0868494617.USD","IE00B4R5TH58.HKD","BK4599","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU2242646821.SGD","IBBQ","IE00B2B36J28.USD","LU1057294990.SGD","LU1983299246.USD","LU2112291526.USD","BK4139","BK4585","BK4588","LU0058720904.USD","BIB","LU0289739699.SGD","BK4566","IE0009355771.USD","TBXU","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169385922","title":"衞材公司：Leqembi Iqlik（Lecanemab-Irmb）自動注射器現已在美國上市，用於早期阿爾茨海默病治療啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=1169385922","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169385922?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 20:04","pubTimestamp":1787573051,"startTime":"0","endTime":"0","summary":"卫材株式会社宣布，其用于启动早期阿尔茨海默病治疗的Leqembi Iqlik自动注射器，现已正式登陆美国市场。与传统的静脉输注方式相比，这款自动注射器的问世，无疑为治疗流程的优化开辟了新的路径。随着该产品在美国的落地，早期阿尔茨海默病患者及其家庭或将迎来更为主动、可控的疾病管理体验。市场观察人士认为，这一创新给药方式的引入，或将对现有治疗格局产生积极而深远的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","PBE","IE00B19Z9P08.USD","LU0234570918.USD","BK4588","BK4585","BK4533","BMED","LU0889565916.HKD","BK4139","BIIB","LU0320765992.SGD","IE00B894F039.SGD","LU0109394709.USD","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291370","title":"美國聯邦貿易委員會（FTC）：安進專利申請收購交易受到反壟斷審查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291370","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291370?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 23:49","pubTimestamp":1787327356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GGTL","JHCS","EMQQ","ARB","RSPT","MSFY","AMGN","BBH","HCA","QQMG","DISC","NBDS","DRUP","JHMT","PJP","PBS","PBE","GXPC","MUSQ","WEBX","TGRW","MNA","IHF","MSFX","BUYO","CWC","BCTK","GOOX","WEBL","FTC","ORCZ","IXP","NBCC","FCOM","IBBQ","IEME","BIB","EVNT","MRGR","TBXU","XLCI","BWEB","TRUC","KEMQ","ONEQ","GXPT","IBB","TDAQ","PNQI","LRGG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250489","title":"Piper Sandler上調安進目標價至457美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250489","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250489?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 15:20","pubTimestamp":1787296801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IBB","LU1983299246.USD","BK4581","IE00BJJMRZ35.SGD","IBBQ","BIB","UUP","BK4534","BK4588","BK4566","LU2242646821.SGD","LU1571399168.USD","IE00B2B36J28.USD","LU0868494617.USD","LU0320765992.SGD","LU2089984988.USD","LU0889565916.HKD","IE0009355771.USD","BK4139","AMGN","IE00B4R5TH58.HKD","LU2112291526.USD","LU1061106388.HKD","LU0109394709.USD","LU0122379950.USD","PBE","BBH","LU1023059063.AUD","LU0058720904.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","TBXU","LU0289739699.SGD","IE00BJT1NW94.SGD","PJP","LU1057294990.SGD","UDN","BK4585","BK4533","IE0002141913.USD","BK4599","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660043834","title":"美國研究綜述-安進、Analog Devices、莫德納","url":"https://stock-news.laohu8.com/highlight/detail?id=2660043834","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660043834?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 15:49","pubTimestamp":1787212153,"startTime":"0","endTime":"0","summary":"美国研究综述-安进、Analog Devices、莫德纳路透8月20日-周四，华尔街证券分析师上调了多家在美国上市公司的评级和目标股价，其中包括安进、模拟设备公司和莫德纳。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4S44H0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1935043536.SGD","LU2125909759.SGD","LU2129689514.USD","LU1935042991.SGD","LU0444973449.USD","IE00B1BXHZ80.USD","VHT","IE00B19Z9P08.USD","LU0417517546.SGD","LU0943347566.SGD","LU1670711123.USD","LU0823417653.USD","LU2506951958.HKD","LU0006306889.USD","LU1084165304.USD","LU2361044865.SGD","SNOU","LU2506951875.HKD","LU2360032135.SGD","LU1235294995.USD","BK4097","PSWD","GLAM","SOXY","IHF","LU1585245621.USD","LU1989764664.SGD","LU0114720955.EUR","LU1169590202.USD","LU0061475181.USD","IE0000B7K699.USD","LU2133065610.SGD","LU2487616109.SGD","LU1623119135.USD","LU1037948897.HKD","SG9999015945.SGD","SGXZ57979304.SGD","IE0002141913.USD","JDOC","LU0795875169.SGD","LU0433182093.SGD","LU2237443978.SGD","LU1162221912.USD","LU2517655374.HKD","LU1267930573.SGD","IE00BD6J9T35.USD","MRVL","LU0708994859.HKD","LU2237443622.USD","MRNX","LU1989763005.USD","LU2552382058.USD","LU1992135472.HKD","TGT","LU2357305700.SGD","LU0786609619.USD","LU1069347547.HKD","LU0081259029.USD","LU0823434583.USD","LU1066051811.HKD","LU2112291526.USD","LU2543165471.USD","LU0128525689.USD","MRVX","BK4560","LU1732799900.SGD","GDOC","SG9999001440.SGD","LU1035773651.USD","LU2458330243.SGD","LU1923622291.USD","SG9999003800.SGD","LU0820561909.HKD","LU1551013425.SGD","BK4114","PCTY","IE000BZT7R73.USD","LU0861579265.USD","LU2125154935.USD","LU2322448791.USD","PJP","LU0320765646.SGD","IE00B5949003.HKD","LU1803068979.SGD","IE00BSNM7G36.USD","LU2041044095.USD","LU2242646821.SGD","LU1718418525.SGD","IE0004086264.USD","LU0029864427.USD","LU1732800096.USD","LU2458330169.SGD","LU0690374961.EUR","LU1169589451.USD","BK4533","LU0077335932.USD","CRWC","BIB","BK4505","BK4585","LU1978683503.SGD","BK4550","LU2023250843.SGD","LU2361045086.USD","IE00BFTCPJ56.SGD","LU2125909916.SGD","LU0109392836.USD","LU2087621335.USD","BK4141","LU2322448957.HKD","LU0203345920.USD","LU2404859741.USD","BK4551","LU1861215975.USD","LU0738911758.USD","LU0985320562.USD","LU1839511570.USD","MRVU","AGNG","LU1992135399.USD","IHE","DTCR","SG9999001176.USD","LU0265550359.USD","LU1941712348.USD","LU2473716301.USD","IE00B2B36J28.USD","LU1023059063.AUD","LU2098885051.SGD","WDNA","LU1823568750.SGD","BK4596","SG9999000418.SGD","BK4501","BK4568","CRWL","LU1093756325.SGD","LU1691799644.USD","IYH","LU1923623000.USD","SG9999002232.USD","LU0950375773.USD","MRNY","LU0211328371.USD","BK4130","IE00B19Z3581.USD","IE0009355771.USD","LOW","SG9999015952.SGD","LU2272731865.HKD","SG9999001176.SGD","LU0154236417.USD","IE000WAW04H5.SGD","IE00BDGV0183.EUR","IE00BMPRXN33.USD","LU1291159041.SGD","GNOM","MRK","BK4515","IE00B19Z3B42.SGD","LU1712237335.SGD","LU0124384867.USD","BK4116","IE00BN8TJ469.HKD","LU2237443895.HKD","LU1244550494.USD","LU0256863811.USD","LU0965509010.AUD","LU1804176565.USD","HAKY","BK4094","LU0942090050.USD","LU1934455277.USD","LU1951200564.SGD","LU0053666078.USD","LU0127658192.USD","LU0130517989.USD","LU0949170772.SGD","LU0052756011.USD","LU0057025933.USD","MRNA","SG9999014021.USD","LU2089284900.SGD","LU0726765562.USD","LU1923622614.USD","LU2552382132.HKD","HRTS","LU0238689110.USD","BK4559","LU2125909247.SGD","LU1267930490.SGD","LU2491050071.SGD","LU0310799852.SGD","ARTY","LU0661504455.SGD","SG9999015358.SGD","LU0868494617.USD","BK4588","LU1674673428.USD","DAT","FXL","LU1670710661.SGD","CIBR","SG9999014005.SGD","LU1852331112.SGD","SG9999014013.SGD","LU1303367103.USD","IE00BZ1G4Q59.USD","LU1989772923.USD","LU1670710588.SGD","SG9999014575.USD","LU2433249047.HKD","IGV","BK4535","LU2506952170.USD","LU0256863902.USD","SG9999014039.USD","BK4503","IE0004445239.USD","LU0724618433.USD","LU0302445910.USD","BK4558","LU0274383776.USD","LU2361044949.HKD","LU0444971666.USD","MVLL","LU0957808578.USD","SNOW","LU0985489474.SGD","LU2023250504.SGD","LU1699723380.USD","BK4083","LU1670627923.USD","LU1316542783.SGD","LU2360106780.USD","BK4566","LU0878866978.SGD","LU0234572021.USD","LU1983299246.USD","LU0098860793.USD","LU0069063385.USD","FTXH","XNTK","BK4139","LU2089283258.USD","SG9999015986.USD","LU1941712264.USD","LU1244550577.SGD","LU0094547139.USD","LU1929549753.HKD","BK4516","IE00B42XCP33.USD","IE0004091025.USD","LU1571399168.USD","LU2517655028.SGD","LU0689472784.USD","SG9999002224.SGD","FHLC","LU1642822529.SGD","LU0472753341.HKD","LU1815336760.USD","IE00BVYPNV92.GBP","LU0965509101.SGD","BK4604","SG9999015978.USD","BMED","LU2506952097.USD","IE00B5TLWC47.USD","LU0208291251.USD","LU1974910355.USD","LU0082616367.USD","LU1489326972.SGD","BK4528","LU2357627491.SGD","MEDX","SG9999014567.USD","LU1934455863.HKD","LU0823416689.USD","PPH","LU0642271901.SGD","LU1150488135.SGD","ADI","BK4597","LU2264538146.SGD","LU0106261372.USD","LU0476273544.USD","XDAT","LU1951198990.SGD","LU0158827948.USD","XLV","LU1116320737.USD","LU0097036916.USD","BBH","WOLF","LU0823421333.USD","LGHT","LU2360108059.USD","LU1989773731.SGD","LU2211815571.USD","LU2931357623.SGD","LU2347655156.SGD","LU1261432733.SGD","LU0511384066.AUD","IE00BLSP4452.SGD","LU1989772840.SGD","LU1917777945.USD","LU0109394709.USD","SMHX","IE000MB6IJN5.SGD","IE0002270589.USD","LU2125909593.SGD","IE0009356076.USD","LU2552382215.SGD","LU0289739343.SGD","IXJ","LU1674673691.USD","IE00B3S45H60.SGD","LU0056508442.USD","LU2355687059.USD","LU0314106906.USD","LU0203347892.USD","LU2125154778.USD","IE00BZ9MQY76.HKD","LU0211331839.USD","LU0980610538.SGD","LU0124676726.USD","BK4598","AIS","IE00BVYPNW00.USD","IBB","BK4599","LU0320765489.SGD","LU1037948541.HKD","LU2491050154.USD","LU1064131342.USD","LU2360107325.USD","CLOD","WISE","CRWD","BK4512","LU2461242641.AUD","LU2491049909.HKD","LU0689626769.HKD","LU2092937221.SGD","LU0266013472.USD","LU0312595415.SGD","LU1150488218.USD","LU1548497426.USD","LU1003077747.HKD","LU2237443465.HKD","TRUH","LU1551013342.USD","LU1496350502.SGD","IE00B19Z9Z06.USD","BK4548","BK4532","LU2023251221.USD","CLOU","IE000SO60NU8.SGD","LU2286300806.USD","IE00BZ199S13.USD","LU0553294199.USD","LU2129689605.HKD","SG9999014559.SGD","04332","PAWZ","LU2089985449.USD","LU0187121727.USD","LU2106854487.HKD","LU2517655291.USD","SG9999014542.SGD","EL","LU2290526834.HKD","IE00B4R5TH58.HKD","LU0128525929.USD","WCBR","LU1267930227.SGD","LU1861220033.SGD","LU1989764748.USD","BK4605","IE00BMPRXR70.SGD","LU0198837287.USD","IE000M9KFDE8.USD","IE00B3PB1722.GBP","BK4023","BK4581","LU1093756168.USD","IE000F7OJYX1.SGD","IE00BGHQF631.EUR","LU0265550946.USD","BK4613","LU0889565833.HKD","LU2237443549.SGD","TBXU","LU2129689431.USD","BK4185","IE00BLSP4239.USD","LU0823421416.USD","LU1057294990.SGD","LU2272731600.USD","LU1066051498.USD","LU1201861249.SGD","BK4554","LU0868494708.USD","LU2275660780.HKD","LU0058720904.USD","LU2404859667.USD","LU0477156953.USD","BK4504","FAI","LU1496350171.SGD","ABBV","LU0310800379.SGD","LU2347655073.USD","BK4607","FTXL","LU1244550221.USD","LU2298322129.HKD","LU0289739699.SGD","LU0823434740.USD","LU2244417387.USD","LU1988902786.USD","LU0289961442.SGD","LU0068578508.USD","PBE","LU2237438978.USD","LU1720051017.SGD","LU0820561818.USD","SG9999015341.SGD","LU0310800965.SGD","LU0823417737.USD","LU1778281490.HKD","LU0690374615.EUR","LU0130102774.USD","FDTX","SNOY","LU2265009873.SGD","LU0912757837.SGD","BK4155","AIFD","LU0965509283.SGD","LU0859254822.USD","LU0889565916.HKD","LU0882574055.USD","BK4561","LU1989771016.USD","LU0234570918.USD","AMGN","BILL","IE00BJT1NW94.SGD","LU2324357040.USD","RXL","LU1861219969.SGD","LU2250418816.HKD","LU1119994496.HKD","AIPI","LU1720051108.HKD","LU1506573853.SGD","IBBQ","WUGI","BK4592","BUG","LU0211327993.USD","SPAM","LU2468319806.SGD","BK4007","LU1670628061.USD","LU1061106388.HKD","SG9999011175.SGD","LU0320765992.SGD","LU1046421795.USD","LU1074936037.SGD","BK4534","LU0648001328.SGD","TJX","LU0965508806.USD","LU0823411888.USD","LU1934455194.USD","LU1116320901.HKD","LU2089984988.USD","LU0122379950.USD","LU0719512351.SGD","LU0395794307.EUR","WDAY","LU0070302665.USD","LU0545039389.USD","LU1066053197.SGD","LU0314104364.USD","LU2237443382.USD","LU2298321311.HKD","IE00B775SV38.USD","LU1430594728.SGD","LU0432979614.USD","HCA","IE00BBT3K403.USD","IE00BMPRXQ63.HKD","IE0034235188.USD","LU1066051225.USD","IDNA","LU2272731782.SGD","BK4183","LU2242652126.USD","LU0795875086.SGD","QQQA","IE00BKVL7J92.USD","BK4543","GTEK","LU1670711040.USD","IE00BJJMRZ35.SGD","LU0456855351.SGD","LU2360107168.USD","IE00B894F039.SGD","SG9999013999.USD","LU0170899867.USD","LU0210528500.USD","LU1861214812.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473644","title":"福泰製藥(VRTX)股票8月19日收盤上漲4.48%：釋放什麼信號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473644","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473644?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 04:16","pubTimestamp":1787170582,"startTime":"0","endTime":"0","summary":"• 在竞争对手临床试验宣告失败后，福泰制药股价飙升至历史新高。\n• 第二季度营收超出预期，公司同时上调了全年业绩指引。\n• 分析师纷纷给出看涨评级，平均目标价达 563.25 美元。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262119125-market-movers-vrtx-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU1585245621.USD","IE00B4R5TH58.HKD","LU2237438978.USD","LU2456880835.USD","LU0234570918.USD","BK4588","LU1035775433.USD","BIB","LU1069344957.HKD","LU2417539215.USD","BK4567","SG9999001176.SGD","LU0320765992.SGD","PBE","IE00B19Z9P08.USD","LU0058720904.USD","LU2236285917.USD","BK4532","TBXU","LU2462157665.USD","VRTX","IDNA","LU0289739699.SGD","LU1093756325.SGD","BBH","SGXZ57979304.SGD","LU0417517546.SGD","LU2468319806.SGD","IE00BJT1NW94.SGD","IBB","LU0109394709.USD","LU0823416689.USD","LU2362541273.HKD","IE00B19Z3B42.SGD","LU2362541513.USD","IE00BFTCPJ56.SGD","BK4139","LU1778281490.HKD","LU0432979614.USD","LU0079474960.USD","IE0009355771.USD","LU1674673428.USD","GNMX","IBBQ","LU1674673691.USD","LU0256863811.USD","IE00B19Z9Z06.USD","IE0002270589.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660819420","title":"安進(AMGN)股票8月19日盤中上漲3.19%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660819420","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660819420?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 02:16","pubTimestamp":1787163383,"startTime":"0","endTime":"0","summary":"• Argus上调安进目标价，并重申“买入”评级。\n• 第二季度财务业绩超出华尔街的营收和盈利预期。\n• 技术指标显示 MACD 买入信号及 RSI 买入条件。","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118749-market-movers-amgn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU0058720904.USD","LU2242652126.USD","LU1023059063.AUD","LU0122379950.USD","LU0289739699.SGD","LU1983299246.USD","LU2468319806.SGD","BK4581","LU1061106388.HKD","PJP","IBB","BK4139","LU0320765992.SGD","IE00B4R5TH58.HKD","LU1571399168.USD","BK4533","IBBQ","BK4585","BK4599","BK4588","LU2242646821.SGD","TBXU","LU0109394709.USD","IE00BFTCPJ56.SGD","BK4534","PBE","IE00BJT1NW94.SGD","BK4566","LU0889565916.HKD","AMGN","LU2089984988.USD","IE0002141913.USD","SG9999001440.SGD","BIB","LU2112291526.USD","LU0868494617.USD","BBH","IE0009355771.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660585446","title":"瑞穗上調安進目標價至352美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660585446","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660585446?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 16:55","pubTimestamp":1787129710,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BFTCPJ56.SGD","LU0889565916.HKD","BBH","BK4534","LU1571399168.USD","LU0122379950.USD","BIB","IE00B2B36J28.USD","LU2089984988.USD","SG9999001440.SGD","BK4585","BK4533","UUP","UDN","IBBQ","LU1023059063.AUD","LU2468319806.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","LU2242646821.SGD","LU0109394709.USD","LU1061106388.HKD","IBB","LU0320765992.SGD","BK4566","LU2242652126.USD","TBXU","LU2112291526.USD","LU1057294990.SGD","AMGN","LU0058720904.USD","BK4139","IE0009355771.USD","BK4599","IE00BJJMRZ35.SGD","LU0289739699.SGD","IE00B4R5TH58.HKD","PJP","BK4581","LU0868494617.USD","LU1983299246.USD","PBE","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431564","title":"駿利亨德森投資：專利到期倒逼藥企擴張 生物科技併購、IPO市場同步復甦","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431564","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431564?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 16:06","pubTimestamp":1787126785,"startTime":"0","endTime":"0","summary":"骏利亨德森投资称，尽管利率较市场年初的预期为高，但生物科技行业交易活动的增长动力持续不减。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4582","FBT","BIB","PBE","BK4588","BBP","SPCK","QSML","MRNY","GTPE","BIS","BBC","IBBJ","IAI","IJT","BK4585","IYG","JDOC","IWO","MRNX","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660416851","title":"藥代違規進入診療區域！湘雅二醫院發藥品「停用函」，艾力斯、賽諾菲、安進、康蒂尼四藥企上「黑榜」","url":"https://stock-news.laohu8.com/highlight/detail?id=2660416851","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660416851?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 09:48","pubTimestamp":1787104101,"startTime":"0","endTime":"0","summary":"湘雅二医院方面向澎湃新闻表示，院方确有发该“协办函”。据此次公布的协办函，对几家涉事药企的处理决定颇为严厉。近年来，医药代表违规已不仅是行业道德问题，而是监管重点。此次湘雅二医院将企业列入购销负面清单，正是医院端落地上述政策的缩影。湘雅二医院相关负责人表示，自国家在2020年底建立医药代表备案制度，医院就积极响应国家政策，并不断完善内部制度和执行流程。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787103396417327872","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4585","LU1057294990.SGD","IBBQ","BK4533","LU2242652126.USD","IE0009355771.USD","LU2468319806.SGD","LU0320765992.SGD","BK4581","BK4139","IE00B2B36J28.USD","688578","IE00BJT1NW94.SGD","LU2089984988.USD","IE0002141913.USD","LU2112291526.USD","BK4534","LU1571399168.USD","IBB","BK4599","BK4566","IE00BJJMRZ35.SGD","BBH","LU1061106388.HKD","LU1023059063.AUD","SG9999001440.SGD","BIB","PBE","AMGN","BK0239","LU0868494617.USD","IE00B4R5TH58.HKD","BK4588","IE00BFTCPJ56.SGD","TBXU","LU0109394709.USD","PJP","LU0122379950.USD","LU2242646821.SGD","LU0889565916.HKD","LU0289739699.SGD","LU1983299246.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192416297","title":"TScan Therapeutics披露：安進將終止與其研究合作及許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1192416297","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192416297?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 05:04","pubTimestamp":1787087050,"startTime":"0","endTime":"0","summary":"值得注意的是，安进作为全球领先的生物制药公司，此举无疑将对TScan Therapeutics的研发管线及未来战略布局产生深远影响。TScan Therapeutics方面表示，将仔细评估这一变化对公司在研项目及整体运营带来的潜在影响。对于TScan Therapeutics而言，此番变故或许意味着需要重新校准其研发路径，并探索新的合作机会或资金来源以继续推进其创新疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","IE0002141913.USD","BK4581","LU1571399168.USD","IE0009355771.USD","BK4566","BK4585","TBXU","AMGN","IBBQ","LU1057294990.SGD","BK4139","LU2242652126.USD","LU0058720904.USD","LU0289739699.SGD","LU2242646821.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","TCRX","BK4599","LU0889565916.HKD","PJP","BIB","LU2468319806.SGD","LU0868494617.USD","LU0122379950.USD","BK4539","LU2089984988.USD","LU0109394709.USD","BK4588","IE00BJT1NW94.SGD","IBB","LU2112291526.USD","PBE","BBH","LU1061106388.HKD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4534","LU1023059063.AUD","SG9999001440.SGD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660101358","title":"巴克萊上調安進目標價至380美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660101358","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660101358?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 11:05","pubTimestamp":1786935953,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["UUP","TBXU","BBH","BK4588","LU2112291526.USD","BK4533","BK4566","AMGN","BK4585","IBBQ","BIB","PBE","LU1571399168.USD","LU1983299246.USD","LU0289739699.SGD","BK4534","BK4139","IE00BJT1NW94.SGD","LU1061106388.HKD","LU2242646821.SGD","SG9999001440.SGD","LU0058720904.USD","LU1057294990.SGD","LU0320765992.SGD","UDN","PJP","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0868494617.USD","LU1023059063.AUD","LU0889565916.HKD","IE0009355771.USD","BK4581","IE0002141913.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU2089984988.USD","IE00B2B36J28.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","BK4599","LU2468319806.SGD","IBB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":3,"totalSize":152,"code":"91000000","status":"200"}]}}